Latest News - Alcon

Tuesday, July 18, 2017 | Earnings & Financials, Alcon

Latest Novartis Earnings Show Signs of a Rebound at Alcon

As part of its second quarter earnings, Novartis reported that sales at its Alcon unit accelerated in the second quarter. Novartis Chief Executive Joe Jimenez said the results increase the number of o…

Read the full story

Wednesday, June 07, 2017 | Medical Studies, Alcon

New Alcon Survey Reveals People are Happier, More Satisfied With Their Lives After Cataract Surgery

A new survey from Alcon demonstrates that people experience significant emotional and lifestyle benefits after cataract surgery. Nearly three in four respondents who expressed an opinion agreed that a…

Read the full story

Thursday, June 01, 2017 | Product Releases, Alcon

Alcon's ORA System with VerifEye Technology Now Available in Canada

Alcon Canada, a division of Alcon, announced that the Valley Laser Eye Centre, in Abbotsford, BC, recently became the first facility in Canada to offer the ORA System with VerifEye technology to patie…

Read the full story

Wednesday, May 31, 2017 | Product Releases, Alcon

Alcon Announces Launch of New DAILIES AquaComfort Plus Patient-Friendly Packaging

Alcon launched new US-specific packaging for DAILIES AquaComfort Plus (DACP) spherical contact lenses in 90-, 30- and 5-packs to assist patients with proper lens wear and care. The new packaging is th…

Read the full story

Wednesday, May 31, 2017 | Partnerships, Alcon

CheckedUp Broadens Its Reach in Ophthalmology

CheckedUp announced the expansion of its existing partnership with Alcon to educate patients about cataract surgical treatment options through the CheckedUp platform. The CheckedUp platform engages pa…

Read the full story

Tuesday, May 16, 2017 | Product Releases, Alcon

Alcon Introduces SYSTANE ICAPS Chewable Eye Vitamin, the First Chewable AREDS2 Formula in the United States

Alcon announced the introduction of SYSTANE ICAPS Chewable AREDS2 eye vitamin in the US market to support eye health in people with intermediate to advanced age-related macular degeneration (AMD).…

Read the full story

Friday, May 05, 2017 | Management/Leadership, Alcon

Stephen S. Lane, MD, Joins Alcon as Chief Medical Officer and Global Head Franchise Clinical Strategy

Alcon has appointed Stephen S. Lane, MD, as Chief Medical Officer and Global Head Franchise Clinical Strategy. He will join the company on June 1. In his new role, Dr. Lane will lead the integratio…

Read the full story

Friday, May 05, 2017 | Product Releases, Alcon

Alcon Introduces Two New Cataract Surgical Technologies at ASCRS

Alcon launched new phaco and femtosecond laser technology innovations at the American Society of Cataract and Refractive Surgery (ASCRS) 2017 annual meeting in Los Angeles. The new Intrepid Transfo…

Read the full story

Wednesday, May 03, 2017 | Conferences, Product Releases, Alcon

Alcon Launches Newly Approved Multifocal Toric IOL with Activefocus, Highlights Other Surgical Innovations at ASCRS

Alcon will launch its AcrySof IQ ReSTOR +2.5 Multifocal Toric IOL with Activefocus optical design at the American Society of Cataract and Refractive Surgery (ASCRS) 2017 annual meeting, taking place M…

Read the full story

Thursday, April 27, 2017 | Product Releases, Alcon

Alcon Launches Two Vitreoretinal Surgical Innovations at the 2017 FLOREtina Retina Meeting

Alcon has introduced the Advanced Ultravit Beveled High Speed Probe and Vektor Articulating Illuminated Laser Probe during the second edition of the FLOREtina Retina Meeting. These new technologies ar…

Read the full story

Wednesday, April 26, 2017 | Earnings & Financials, Alcon

Novartis Pushes Pipeline But Keeps An Eye On Alcon

Investors reacted well to a decent first quarter from Novartis that suggested that the long-awaited turnaround in its Alcon eyecare division has begun. While there is still investment needed, especial…

Read the full story

Thursday, March 23, 2017 | FDA Approval/Clearance, Alcon

Alcon Receives FDA Approval for AcrySof IQ ReSTOR +2.5 Multifocal Toric IOL with Activefocus

Alcon has received approval from the FDA for its AcrySof IQ ReSTOR +2.5 Multifocal Toric IOL with Activefocus, which is designed to address astigmatism and presbyopia at the same time. The unique opti…

Read the full story

Monday, March 06, 2017 | Product Releases, Alcon

Alcon Launches New Digital Vision Care Marketing Portal for Eye Care Professionals


Alcon announced the launch of a comprehensive marketing portal with digital resources and content to help eye care professionals (ECPs) strengthen their online outreach to patients, according to a com…

Read the full story

Friday, March 03, 2017 | Health Care, Alcon

Alcon Supports Eye Health with Charitable Giving of Nearly $73 Million in 2016 and Renews Commitment to Think About Your Eyes Campaign

Alcon directly supported eye health in 2016 with nearly 650 medical missions that served more than 480,000 patients around the world and facilitated more than 47,000 surgeries, acording to a company n…

Read the full story

Thursday, January 26, 2017 | Product Releases, Alcon

Alcon Launches New Trifocal Toric IOL for Patients with Astigmatism Undergoing Cataract Surgery

Alcon announced the launch of AcrySof IQ PanOptix Toric presbyopia- and astigmatism-correcting IOL for patients with preexisting corneal astigmatism undergoing cataract surgery. It is a new option for…

Read the full story
Load More